U.S. Markets closed

Elite Pharmaceuticals, Inc. (ELTP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.193-0.01 (-3.17%)
At close: 3:58PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue9,637.71512,498.3325,015.246
Cost of Revenue5,898.4054,484.1623,013.592
Gross Profit3,739.318,014.172,001.654
Operating Expenses
Research Development8,301.69312,428.78314,727.472
Selling General and Administrative2,441.1813,236.543,164.159
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-7,355.933-8,316.8-16,506.972
Income from Continuing Operations
Total Other Income/Expenses Net9,537.7237,394.00622,011.559
Earnings Before Interest and Taxes2,181.79-922.7945,504.587
Interest Expense238.223280.67287.231
Income Before Tax1,943.567-1,203.4645,217.356
Income Tax Expense-1,867.614-520.452-3.249
Minority Interest---
Net Income From Continuing Ops3,811.181-683.0125,220.605
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,811.181-683.0125,220.605
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares24,525.467-9,968.72728,929.674